Feature

Rare pediatric cancers persist 63 years after nuclear accident


 

Failure to come clean

In 2008, a law that set standards for cleanup of the site was passed. But the law was overturned in 2014 after a legal challenge by Boeing.

That left in place a 2007 order of consent between Boeing, NASA, the U.S. Department of Energy, and the California Department of Toxic Substances Control (DTSC) that required cleanup of SSFL to a much less stringent standard.

As of last year, Boeing and DTSC had begun confidential, nonbinding agreements regarding the 2007 order of consent, according to Parents Against SSFL.

Among the contaminants lingering at the site are radioactive particles, chemical compounds, heavy metals, and polluted water.

“In fact, over 300 contaminants of concern have been found at the site, and they are refusing to clean it,” Mr. Hirsch said. “This company releases large amounts of carcinogens, and perhaps significant numbers of people get sick with cancer, and the company doesn’t go to prison. They get more federal contracts.”

A version of this article first appeared on WebMD.com.

April 20, 2022 – Editor’s note: This article has been updated to include an interview with Dr. Thomas Mack, former director of the Los Angeles County Cancer Surveillance Program, who contends that there is insufficient evidence to support a direct link between the 1959 reactor accident and recent incident cancers.

Pages

Recommended Reading

New trials in leukemia: Could your patient benefit?
MDedge Hematology and Oncology
Immunotherapies for children with r/r ALL face off
MDedge Hematology and Oncology
Treating ALL: Asparaginase enzyme levels linked to toxicities
MDedge Hematology and Oncology
Customizing pre-CAR T chemotherapy could improve ALL patient outcomes
MDedge Hematology and Oncology
For leukemias, COVID-19 death risks tied to poor prognoses, ICU deferrals
MDedge Hematology and Oncology
TKI/BiTE combo extends survival of older patients with Ph+ALL
MDedge Hematology and Oncology
ASH studies look at racial disparities in ALL care, outcomes
MDedge Hematology and Oncology
DKMS: Small nonprofit to world’s largest stem cell donor registry
MDedge Hematology and Oncology
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'
MDedge Hematology and Oncology
CLL patients ‘cured’: 10 years post infusion, CAR T cells persist
MDedge Hematology and Oncology